M&A

The age of risk has just begun and Marsh & McLennan quickly cements its position in the market acquiring Jardine Lloyd Thompson for $5.6bn

Marsh & McLennan Companies [MMC:NYSE] – Market Cap 42,252bn Jardine Lloyd Thompson plc [JLT.T:LSE] – Market Cap 4,025bn Introduction  On September 18, 2018, the New-York-based conglomerate Marsh & McLennan Companies Inc. (“MMC”), a global leader in the fields of risk, strategy and people, acquired the lower-scaled UK rival Jardine Lloyd Read more…

By BSIC, ago

When “subject to regulatory approval” means troubles: forms of government intervention in M&A transactions

Introduction A persistent financial crisis, the rising of regional tensions, the concerns of a trade war and many other facts have recently been catching up with the M&A-friendly international environment. Protectionism seems now to pervade the new world order. Rising economic nationalism is threatening to impact M&A activity across all Read more…

By BSIC, ago

Cigna Corporation and Express Scripts: a $67bn deal for their survival in the US healthcare industry

CIGNA Corporation (NYSE:CI) – market cap as of 09/03/2018: $42.7bn Express Scripts Holding Co (NASDAQ:ESRX) – market cap as of 09/03/2018: $45.7bn Introduction On March 8, 2018, Cigna Corporation announced the acquisition of Express Scripts Holding for a cash and stock consideration of $67bn. The combination of Cigna – a Read more…

By BSIC, ago